Vanguard Group »

Mineralys Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 1.2M 11.70
2024-03-31 $13M 983k 12.91
2023-12-31 $8.4M 978k 8.60
2023-09-30 $8.9M 938k 9.51
2023-06-30 $16M 926k 17.05
2023-03-31 $4.6M 292k 15.66